336 related articles for article (PubMed ID: 26874840)
21. Sensorimotor white matter projections and disease severity in primary Restless Legs Syndrome/Willis-Ekbom disease: a multimodal DTI analysis.
de Paiva JPQ; Magalhães SC; Moura LM; Sato JR; Amaro E; Sterr A; Schlaffke L; Eckeli AL; do Prado GF; Conforto AB
Sleep Med; 2020 Sep; 73():106-116. PubMed ID: 32805477
[TBL] [Abstract][Full Text] [Related]
22. Consensus clinical practice guidelines for the diagnosis and treatment of restless legs syndrome/Willis-Ekbom disease during pregnancy and lactation.
Picchietti DL; Hensley JG; Bainbridge JL; Lee KA; Manconi M; McGregor JA; Silver RM; Trenkwalder C; Walters AS;
Sleep Med Rev; 2015 Aug; 22():64-77. PubMed ID: 25553600
[TBL] [Abstract][Full Text] [Related]
23. Restless legs syndrome/Willis-Ekbom disease diagnostic criteria: updated International Restless Legs Syndrome Study Group (IRLSSG) consensus criteria--history, rationale, description, and significance.
Allen RP; Picchietti DL; Garcia-Borreguero D; Ondo WG; Walters AS; Winkelman JW; Zucconi M; Ferri R; Trenkwalder C; Lee HB;
Sleep Med; 2014 Aug; 15(8):860-73. PubMed ID: 25023924
[TBL] [Abstract][Full Text] [Related]
24. D3 receptor agonist efficacy in restless legs syndrome.
Casoni F; Galbiati A; Ferini-Strambi L
Adv Pharmacol; 2019; 84():21-35. PubMed ID: 31229173
[TBL] [Abstract][Full Text] [Related]
25. The prevalence of the restless legs Syndrome/Willis-Ekbom disease among teenagers, its clinical characteristics and impact on everyday functioning.
Pienczk-Ręcławowicz K; Pilarska E; Olszewska A; Ręcławowicz D; Konieczna S; Sławek J
Sleep Med; 2022 Jan; 89():48-54. PubMed ID: 34883398
[TBL] [Abstract][Full Text] [Related]
26. Intractable restless legs syndrome: role of prolonged-release oxycodone-naloxone.
de Biase S; Valente M; Gigli GL
Neuropsychiatr Dis Treat; 2016; 12():417-25. PubMed ID: 26966363
[TBL] [Abstract][Full Text] [Related]
27. New concepts in the management of restless legs syndrome.
Garcia-Borreguero D; Cano-Pumarega I
BMJ; 2017 Feb; 356():j104. PubMed ID: 28242627
[TBL] [Abstract][Full Text] [Related]
28. Restless Legs Syndrome and Parkinson Disease: A Causal Relationship Between the Two Disorders?
Ferini-Strambi L; Carli G; Casoni F; Galbiati A
Front Neurol; 2018; 9():551. PubMed ID: 30087647
[TBL] [Abstract][Full Text] [Related]
29. A prospective study of Willis-Ekbom disease/restless legs syndrome during and after pregnancy.
Neyal A; Senel GB; Aslan R; Nalbantoglu M; Acikgoz S; Yilmaz N; Tumay FB; Neyal M; Karadeniz D
Sleep Med; 2015 Sep; 16(9):1036-40. PubMed ID: 26298776
[TBL] [Abstract][Full Text] [Related]
30. Dopaminergic Augmentation in Restless Legs Syndrome/Willis-Ekbom Disease: Identification and Management.
García-Borreguero D
Sleep Med Clin; 2015 Sep; 10(3):287-92, xiii. PubMed ID: 26329438
[TBL] [Abstract][Full Text] [Related]
31. What treatment works best for restless legs syndrome? Meta-analyses of dopaminergic and non-dopaminergic medications.
Hornyak M; Scholz H; Kohnen R; Bengel J; Kassubek J; Trenkwalder C
Sleep Med Rev; 2014 Apr; 18(2):153-64. PubMed ID: 23746768
[TBL] [Abstract][Full Text] [Related]
32. Aripiprazole, a Novel Option in the Management of Restless Legs Syndrome (RLS) Patients with Augmentation and/or Severe RLS Symptoms: A Report of 4 Cases.
Lee EK; Spitale N; Robillard R
Nat Sci Sleep; 2023; 15():779-784. PubMed ID: 37818170
[TBL] [Abstract][Full Text] [Related]
33. Short-interval intracortical inhibition is decreased in restless legs syndrome across a range of severity.
Magalhães SC; Queiroz de Paiva JP; Kaelin-Lang A; Sterr A; Eckeli AL; Winkler AM; Fernandes do Prado G; Amaro E; Conforto AB
Sleep Med; 2019 Oct; 62():34-42. PubMed ID: 31539846
[TBL] [Abstract][Full Text] [Related]
34. Restless Legs Syndrome and the Use of Antipsychotic Medication: An Updated Literature Review.
Saber WK; Almuallim AR; Algahtani R
Cureus; 2022 Aug; 14(8):e27821. PubMed ID: 36134065
[TBL] [Abstract][Full Text] [Related]
35. A review of current treatment strategies for restless legs syndrome (Willis-Ekbom disease).
Klingelhoefer L; Cova I; Gupta S; Chaudhuri KR
Clin Med (Lond); 2014 Oct; 14(5):520-4. PubMed ID: 25301914
[TBL] [Abstract][Full Text] [Related]
36. Quantitative sensory test for primary restless legs syndrome/Willis-Ekbom disease using the current perception threshold test.
Cho YW; Kang MS; Kim KT; Do SY; Lim JG; Lee SY; Motamedi GK
Sleep Med; 2017 Feb; 30():19-23. PubMed ID: 28215248
[TBL] [Abstract][Full Text] [Related]
37. "Emplotted Narratives" and Structured "Behavioral Observations" Supporting the Diagnosis of Willis-Ekbom Disease/Restless Legs Syndrome in Children with Neurodevelopmental Conditions.
Ipsiroglu OS; Beyzaei N; Berger M; Wagner AL; Dhalla S; Garden J; Stockler S
CNS Neurosci Ther; 2016 Nov; 22(11):894-905. PubMed ID: 27292821
[TBL] [Abstract][Full Text] [Related]
38. Proteomic analysis of the cerebrospinal fluid of patients with restless legs syndrome/Willis-Ekbom disease.
Patton SM; Cho YW; Clardy TW; Allen RP; Earley CJ; Connor JR
Fluids Barriers CNS; 2013 Jun; 10(1):20. PubMed ID: 23758918
[TBL] [Abstract][Full Text] [Related]
39. Restless Legs Syndrome/Willis-Ekbom Disease Morbidity: Burden, Quality of Life, Cardiovascular Aspects, and Sleep.
Stevens MS
Sleep Med Clin; 2015 Sep; 10(3):369-73, xv-xvi. PubMed ID: 26329447
[TBL] [Abstract][Full Text] [Related]
40. Restless Leg Syndrome/Willis-Ekbom disease in women with iron deficiency anemia.
Kolukisa M; Soysal P; Gületkin TÖ; Karatoprak C; Bilgen HR; Gürsoy AE
Ideggyogy Sz; 2016 Sep; 69(9-10):356-360. PubMed ID: 29638100
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
